Zobrazeno 1 - 10
of 401
pro vyhledávání: ''
Autor:
Christian Lang, Felix Egger, Mir Alireza Hoda, Alessandro Saeed Querner, Bence Ferencz, Victor Lungu, Robert Szegedi, Levente Bogyo, Klara Torok, Felicitas Oberndorfer, Thomas Klikovits, Anna Schwendenwein, Kristiina Boettiger, Ferenc Renyi-Vamos, Konrad Hoetzenecker, Karin Schelch, Zsolt Megyesfalvi, Balazs Dome
Publikováno v:
Lung Cancer. 169:40-46
The prognostic value of lymphocyte-to-monocyte ratio (LMR) has already been evaluated in a wide range of malignancies including patients with non-surgically managed small cell lung cancer (SCLC). However, the impact of LMR on survival in surgically t
Autor:
Ludovic Fournel, Thomas Charrier, Maxime Huriet, Amedeo Iaffaldano, Audrey Lupo, Diane Damotte, Jennifer Arrondeau, Marco Alifano
Publikováno v:
Lung Cancer. 166:221-227
Prediction of prognosis is a key step of malignant pleural mesothelioma (MPM) management and treatment assignment. Aim of this study was to identify simple prognostic factors, focusing on inflammation-related parameters.Baseline clinical and laborato
Publikováno v:
Lung Cancer. 158:47-54
Objectives As a poor prognostic factor, visceral pleural invasion (VPI) was incorporated into non-small cell lung cancer (NSCLC) staging system. For modifying the T description of NSCLC, the prognostic value of VPI was assessed. Materials and Methods
Autor:
Ariana Pereira García, Christian Rolfo, Luis E. Raez, Andrés F. Cardona, Luis Lara-Mejía, Alejandro Aviles Salas, Enrique Caballé Pérez, Oscar Arrieta, Diego Díaz-García, Ixel Escamilla, Rafael Rosell
Publikováno v:
Repositorio U. El Bosque
Universidad El Bosque
instacron:Universidad El Bosque
Universidad El Bosque
instacron:Universidad El Bosque
Introduction Brain metastases (BM) are frequent among lung cancer patients, affecting prognosis and quality of life. The International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS) and European Respiratory Society
Autor:
Marco Lucchi, Lorena Costardi, Angelo Morelli, Domenico Viggiano, Angela De Palma, Filippo Tommaso Gallina, Michele Rusca, Giovanni Muriana, Silvia Ceccarelli, Andrea De Vico, Lorenzo Spaggiari, Giuseppe Marulli, Roberto Crisci, Angelo Carretta, Lorenzo Rosso, Enrico Ruffini, Paolo Mendogni, Francesco Puma, Luigi Ventura, Francesco Londero, Luca Bertolaccini, Edoardo Bottoni, Federico Rea, Marco Alloisio, Giuseppe Cardillo, Marco Schiavon, Maria Teresa Congedo, Nicola Tamburini, Pio Maniscalco, Giampiero Negri, Francesco Facciolo, Sara Ricciardi, Stefano Margaritora, Stefano Bongiolatti, Ilaria Ceccarelli, Luca Voltolini
Publikováno v:
Lung Cancer. 154:29-35
Backgrounds Oligometastatic Non-Small Cell Lung Cancer (NSCLC) patients represent a category without a standard therapeutic approach. However, in selected oligometastatic NSCLC, radical surgery seems to offer a good prognosis. This retrospective stud
Autor:
Thomas Tsitsias, Tom Routledge, John Pilling, Lukacs Veres, Lawrence Okiror, Juliet King, Karen Harrison-Phipps, Andrea Bille
Publikováno v:
Lung Cancer. 151:84-90
Objective to validate the proposed N descriptor revision on a large cohort of patients and assess the impact of tumour location on the distribution pattern of lymph node metastases for patients with NSCLC. Methods This is a retrospective review of a
Autor:
Shoichi Mori, Hisao Asamura, Ichiro Yoshino, Yasushi Shintani, Hiroshi Date, Etsuo Miyaoka, Meinoshin Okumura, Jiro Okami, Takashi Ohtsuka, Masayuki Chida, Ryoichi Nakanishi, Takeshi Nagayasu, Hiroyuki Ito, Takeshi Mori, Koichi Fukumoto, Shinichi Toyooka, Shunsuke Endo, Shun Ichi Watanabe
Publikováno v:
Lung Cancer. 149:120-129
The aim of this study was to evaluate the impact of the preoperative body mass index (BMI) on the postoperative outcomes in patients with completely resected non-small cell lung cancer (NSCLC).The data of patients with NSCLC in whom R0 resection was
Autor:
Isamu Okamoto, Yuichi Takiguchi, Nobuyuki Yamamoto, Ichiro Yoshino, Takehito Shukuya, Etsuo Miyaoka, Koichi Takayama, Kazuhisa Takahashi, Yasushi Shintani, Meinoshin Okumura, Katsuhiko Naoki, Satoshi Igawa, Ikuo Sekine, Katsuyuki Kiura, Akira Inoue
Publikováno v:
Lung Cancer. 146:160-164
Objectives Most patients with small-cell lung cancer (SCLC) experience relapse because of the emergence of drug-resistant tumor cells. Therefore, second-line therapy is subsequently required to prolong their survival. However, it is unclear whether s
Autor:
Sang-Won Um, Bo-Guen Kim, Joungho Han, Hojoong Kim, Jhingook Kim, Jong Ho Cho, Byeong-Ho Jeong, Kyungjong Lee
Publikováno v:
Lung Cancer. 146:58-65
Objectives Primary pulmonary salivary gland-type tumors (PSGT) are rare among all types of lung cancer. The purpose of this study was not only to evaluate the clinical outcomes and prognostic factors after treatment, but also to assess the role for b
Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC)
Publikováno v:
Lung Cancer. 143:40-46
Objectives Little is known regarding the ICPi efficacy in LCNEC. We explored the efficacy and safety of ICPi in LCNEC and assessed its impact on OS. Materials and methods Thirty-seven consecutive patients with advanced LCNEC were selected from the Da